Navigation Links
New England Peptide, Inc. and Cambridge Isotope Laboratories, Inc. Announce Quantitative Proteomics Manufacturing Collaboration
Date:7/16/2013

Gardner, MA (PRWEB) July 16, 2013

New England Peptide, Inc. (NEP) and Cambridge Isotope Laboratories, Inc. (CIL) announced a joint manufacturing and marketing agreement of pre-loaded resins for the synthesis of peptide stable isotope standards (SIS).

Under the terms of the agreement CIL will provide high purity stable isotope amino acids to NEP and NEP will load the isotopologues onto peptide synthesis resins, perform quality control on the resins, and redistribute to CIL. Both companies have agreed to co-market and sell the pre-loaded resins to peptide synthesis laboratories worldwide.

"We saw this collaboration as an important way to facilitate the synthesis of peptide stable isotope standards (SIS). This product will increase the availability and decrease the cost of SIS peptides, which will help the quantitative proteomics field grow", commented Sam Massoni, President and CEO of New England Peptide, Inc.

The gold standard for MS-based quantitative methods is to use a mass-shifted, stable-isotope-labeled peptide standard spiked into the sample of interest, which then allows quantification from a simple ratio of the labeled peak height to the unlabeled. This collaboration is further evidence of NEP and CIL’s commitment to the field.

"We were the first company to manufacture protected stable isotope labeled amino acids at 99% isotopic enrichment. NEP was one of the reasons we have been expanding our production of these 99% enriched reagents. NEP requested the highest quality reagents to meet the increased demand of SIS peptides, and we met that need. This collaboration is a natural fit for both companies and adds value to both product lines", commented Maureen Duffy, VP of Sales and Marketing at Cambridge Isotope Laboratories, Inc.

NEP is one of the premier peptide synthesis companies.

About New England Peptide (NEP)

New England Peptide, founded in 1998, designs and manufactures peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the Boston metro area in Gardner, MA., the company’s chemists and immunological experts specialize in delivering a full range of services for biotech and pharmaceutical applications. NEP is a worldwide leader in providing SIS peptides for the quantitative proteomics field. More information on NEP can be found at http://www.newenglandpeptide.com.

About Cambridge Isotope Laboratories, Inc. (CIL)

CIL is the world’s leading manufacturer of stable isotope labeled reagents for research applications in proteomics, genomics, molecular biology, metabolic research, clinical and diagnostic research and ultra trace environmental analysis. For over 30 years CIL has provided over 15,000 different research compounds to its base of over 35,000 medical, pharmaceutical, academic and government customers.

CIL corporate headquarters are located in Tewksbury, MA. More information on CIL can be found at http://www.isotope.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10920006.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Rates of infection in intensive care units in England show impressive fall
2. University of New England and Partners Celebrate Opening of Portland Community Health Center at Riverton June 20 for Underserved Populations
3. National HealthCare Associates Acquires Five New Centers throughout New England
4. University of New England Graduates First Class with Pharmacy Doctoral Degrees
5. Luke Cooper, CEO, Asurvest, Inc., Nominated For The New England Patriots Myra Kraft Community MVP Award
6. Moderate Red Tide Expected in New England This Summer
7. Hospital remains most common place of death for cancer patients in England
8. Cosmetic Enhancement Center of New England Now Has Satellite Locations
9. New Englanders Without IVF Coverage Have a More Affordable Way to Seek Help Through the WINFertility® Treatment Program
10. Just a drop? Alcohol consumption much higher than reported in England
11. Care New England Executive selected for prestigious program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... In the crowded ... is a stand-out company for several differences from other mainstream brands. , ... demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html . It allows them ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... events, Dr. Carol Francis re-releases powerfully uplifting interview with medical expert and prolific ... everyone endure and pass through tough times, Dr. Bernie Siegel energizes listeners to ...
(Date:1/17/2017)... ... ... SunView Software’s Service Smart Technology has been selected as a finalist for ... year, Pink Elephant recognizes a new product or service developed by an IT services ... opportunity. The award highlights original innovations that were released in 2016, either as a ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... enthusiasts at the National Association of Music Merchants (NAMM) winter trade show, Booth ... 2017. , Etymotic’s ER•4® has long been the gold standard for high-definition, in-ear ...
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve TMS West, with multiple ... new office in San Clemente, California this month. Achieve TMS West is the ... treating individuals struggling with major depression. Depression impacts over 15 million adults in ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global artificial pancreas devices system market to ... Global Artificial Pancreas Devices System Market 2016-2020, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:1/17/2017)... , Jan. 17, 2017 Paragon Bioservices received ... product development services for a variety of ... medical product development activities. The IDIQ mechanism ... pool for task order awards up to $159 ... in manufacturing and process development of biopharmaceuticals, is ...
(Date:1/17/2017)... 2017  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... in a Phase 3 clinical trial comparing the efficacy ... in the prevention of hepatic veno-occlusive disease (VOD) in ... (HSCT) who are at high risk or at very ... will be conducted across approximately 100 medical centers in ...
Breaking Medicine Technology: